Bowler Metcalf Limited (JSE:BCF)

CTI BioPharma Ratios and Metrics

Market cap in millions ZAR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	928	757	703	671	676	506
Market Cap Growth	43.34%	7.54%	4.92%	-0.85%	33.53%	-2.38%
Enterprise Value	810	561	551	496	295	151
Last Close Price	13.50	10.49	9.08	8.38	7.20	5.25
PE Ratio	7.99	7.05	10.24	8.11	7.39	6.14
Forward PE	-	5.65	5.65	5.65	5.65	5.65
PS Ratio	1.05	0.88	0.98	1.00	1.06	0.91
PB Ratio	1.11	0.94	0.97	0.95	0.92	0.74
P/TBV Ratio	1.11	0.94	0.97	0.96	0.93	0.75
P/FCF Ratio	-	25.06	9.36	383.36	17.72	6.20
P/OCF Ratio	14.48	5.66	6.12	23.15	6.12	5.32
PEG Ratio	-	0.39	0.39	0.39	0.39	0.39
EV/Sales Ratio	0.91	0.65	0.77	0.74	0.46	0.27
EV/EBITDA Ratio	5.21	3.95	5.96	4.26	2.27	1.43
EV/EBIT Ratio	6.08	4.64	7.57	4.95	2.65	1.68
EV/FCF Ratio	-22.26	18.60	7.33	283.42	7.72	1.84
Debt / Equity Ratio	-	-	0.00	0.01	0.00	0.01
Debt / EBITDA Ratio	-	-	0.03	0.04	0.01	0.03
Debt / FCF Ratio	-	-	0.04	2.58	0.04	0.04
Asset Turnover	0.97	0.98	0.87	0.82	0.80	0.74
Inventory Turnover	4.65	4.59	3.69	3.76	4.41	4.61
Quick Ratio	4.00	4.90	4.16	4.32	4.80	8.68
Current Ratio	6.38	6.68	5.84	6.36	6.33	10.32
Return on Equity (ROE)	14.56%	14.03%	9.59%	11.51%	12.94%	12.13%
Return on Assets (ROA)	9.16%	8.58%	5.51%	7.65%	8.72%	7.39%
Return on Capital (ROIC)	10.45%	9.86%	6.32%	8.67%	9.80%	8.24%
Return on Capital Employed (ROCE)	15.20%	14.40%	9.60%	13.70%	14.70%	12.70%
Earnings Yield	12.51%	14.19%	9.77%	12.33%	13.53%	16.29%
FCF Yield	-3.92%	3.99%	10.69%	0.26%	5.64%	16.13%
Dividend Yield	4.52%	5.89%	4.45%	5.54%	7.14%	8.85%
Payout Ratio	36.62%	31.14%	43.10%	116.78%	38.44%	37.45%
Buyback Yield / Dilution	-0.00%	0.89%	2.45%	1.02%	3.27%	9.05%
Total Shareholder Return	4.52%	6.78%	6.90%	6.55%	10.42%	17.90%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.